Experts: People have heard a request to stay at home, they tend to get vaccinated, but the mutated virus may already be in Lithuania



[ad_1]

Simon Krėpšta, the president’s chief economic adviser, said the latest analysis of the pandemic process, preparation for vaccination and recommendations on how to improve the treatment of patients through the use of good practices were discussed.

“It is too early to draw any conclusions about the effects of the quarantine.” Population mobility has fallen very steeply since last Wednesday and has largely reached the level seen in the first quarantine in individual categories, “said the adviser.

According to him, this provides optimism for the future.

As Mindaugas Stankūnas, a professor at the Lithuanian Health Sciences University (LSMU), said on Tuesday, changes in mobility are tracked by Google reports.

“In different categories, they show that, say, store mobility is down 60 percent from baseline and this is close to the level that was seen during the first quarantine. There is also a decrease in other categories, “the president’s adviser told reporters.

People are willing to get vaccinated

According to him, a population survey was discussed on Tuesday, showing that two-thirds of the country’s population plans to get vaccinated. “It would guarantee so-called herd immunity,” he said. Half of those who agree to be vaccinated, he said, will get vaccinated as soon as possible.

“You can say that two thirds of people are in favor of the vaccine,” he stressed.

S.Krėpšta specified that 68 percent. responded that they would agree and respondents were asked if they would agree to be vaccinated with a safe coronavirus vaccine.

Offers constant mutation tracking

Edita Sužiedėlienė, a professor at Vilnius University, said that after receiving data on the vaccine, it can be seen that the efficacy is similar for different age groups, reaching 95 percent. A similar level of efficiency is sought for risk groups.

According to E.Sužiedėlienė, local reactions occurred more frequently during vaccination, as well as systemic reactions such as fever. Cases of severe allergies, according to her, were few.

Speaking of mutations in the virus, the professor said that we have probably also imported variants of the virus into Lithuania.

“There is a need to monitor the spread of these variants and to do continuous monitoring, but there is a big problem with monitoring: you need to do a full analysis of the viral genome, and Britain has developed such large-scale studies. we can brag about that, “he said.

According to the professor, Lithuania should start to constantly investigate which variants of the virus are circulating in society.

“The Council of Experts at this point recommends consolidating the strengths and competencies of researchers in scientific centers so that the genomes of viruses circulating in Lithuania can be systematically started without delay,” he said.

What do you need?

According to her, the necessary equipment in our country is really available, it is true that it needs financing, because reagents are cheap.

“The competitions are, I would say, sufficient,” he stressed.

It cannot be ruled out that the mutated virus is present in Lithuania

Mindaugas Stankūnas, a professor at the Lithuanian Health Sciences University (LSMU), said that the speed of the epidemic is increasing but is expected to slow down.

“So far, sadly, the trends are such that we are seeing an increasing number of cases. It is of particular concern that the number of cases per day is high,” he said.

The professor also stated that the possibility that the mutated virus is present in Lithuania cannot be ruled out.

On Tuesday, he said he believed the expert advice convened by the government and the president did not contradict each other.

Preparing for the first vaccination

The European Commission officially authorized the distribution of a coronavirus vaccine developed by BioNTech and Pfizer in the European Union on Monday.

The first shipment of coronavirus vaccines will arrive in Lithuania on December 26 and vaccination will begin on December 27. The vaccines will be delivered periodically, according to an agreed schedule, to all countries of the European Union.

Doctors working in health centers will be vaccinated first. In the second phase, vaccines will be administered to staff and patients in care facilities that provide supportive care and nursing care. These groups should be vaccinated in the first quarter of the year, followed by the public.



[ad_2]